Skip to main content
. 2022 Jan 20;26(Suppl 1):S57–S67. doi: 10.5213/inj.2142100.050

Fig. 1.

Fig. 1.

The intravesical PRP injection for the patients with IC/BPS. (A) The endoscopic injection needle was inserted to the bladder submucosal space. (B) 0.5-mL PRP was pushed into the submucosal pace, with the bladder mucosa bulging up. (C) A total of 20 sites was injected in bladder posterior and lateral walls except trigone. PRP, platelet-rich plasma; IC/BPS, interstitial cystitis/bladder pain syndrome.